Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin

Biochemical Journal

Volumn 356, Issue 3, 2001, Pages 705-718

  Marchenko, G N ^a   Ratnikov, B I ^a   Rozanov, D V ^a   Godzik, A ^a   Deryugina, E I ^a   Strongin, A Y ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Carcinomas; Collagenase; Epithelial cancer; Gelatinase; MMP

Indexed keywords

COLLAGEN; FIBRONECTIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 26; UNCLASSIFIED DRUG; VITRONECTIN;

AMINO ACID SEQUENCE; ARTICLE; BREAST CARCINOMA; CANCER CELL; COMPUTER MODEL; ENZYME ANALYSIS; ENZYME ISOLATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LIBRARY; GENETIC CODE; HUMAN; LUNG CARCINOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CATALYTIC DOMAIN; CLONING, MOLECULAR; DNA PRIMERS; EPITHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, SECRETED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS;

URIA;

EID: 0035875151     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3560705     Document Type: Article

References (59)

1. Matrix metalloproteinases: Structures, evolution, and diversification
2. Proteolysis and cell migration: Creating a path?
3. Matrix metalloproteinases
4. Membrane-type matrix metalloproteinases
5. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
6. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression
7. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution
8. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family
9. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2
10. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
11. The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain
12. A helping hand for collagenases: The haemopexin-like domain
13. Human 92 kDa type IV collagenase: Functional analysis of fibronectin and carboxyl-end domains
14. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2
15. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
16. Cysteine array matrix metalloproteinase (CAMMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation
17. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
18. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
19. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
20. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor
21. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
22. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3
23. Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target
24. 3 in tumor cells expressing membrane type 1 matrix metalloproteinase
25. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: Involvement in MMP2 activation and platelet aggregation
26. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
27. Regulation of cell invasion and morphogenesis in a three-dimensional type 1 collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3
28. Matrix metallproteinases: Multifunctional contributors to tumor progression
29. Cloning of MMP26. A novel matrilysin-like proteinase
30. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors
31. Epilysin: A novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury
32. Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity
33. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor
34. CA-MMP: A matrix metalloproteinase with a novel cysteine array, but without the classic cysteine switch
35. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP
36. Leukolysin/MMP25/MT6-MMP: A novel matrix metalloproteinase specifically expressed in the leukocyte lineage
37. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity
38. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members
39. Human MT6-matrix metalloproteinase: Identification, progelatinase A activation, and expression in brain tumors
40. Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development
41. Determination of matrix metalloproteinase activity using biotinylated gelatin
42. MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors
43. Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domain
44. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases
45. Characterization of rat uterine matrilysin and its cDNA. Relationship to human pump-1 and activation of procollagenases
46. Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively
47. The Ets family of transcription factors
48. Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme
49. Matrilysin-inhibitor complexes: Common themes among metalloproteases
50. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor
51. Understanding the P1′ specificity of the matrix metalloproteinases: Effect of S1′ pocket mutations in matrilysin and stromelysin-1
52. Comparison of sequence profiles. Strategies for structural predictions using sequence information
53. Comparative protein modelling by satisfaction of spatial restraints
54. Classical electrostatics in biology and chemistry
55. GRASS: A server for the graphical representation and analysis of structures
56. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
57. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
58. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland
59. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin